These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Relationship between clozapine dose and severity of obsessive-compulsive symptoms. Kim DD; Barr AM; Stewart SE; White RF; Honer WG; Procyshyn RM Med Hypotheses; 2021 Mar; 148():110506. PubMed ID: 33515917 [TBL] [Abstract][Full Text] [Related]
46. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms. Ma N; Tan LW; Wang Q; Li ZX; Li LJ Psychiatry Res; 2007 Feb; 150(1):61-9. PubMed ID: 17291595 [TBL] [Abstract][Full Text] [Related]
47. Obsessive-compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders. De Haan L; Oekeneva A; Van Amelsvoort T; Linszen D Eur Psychiatry; 2004 Dec; 19(8):524. PubMed ID: 15589719 [No Abstract] [Full Text] [Related]
48. Relationship of obsessive compulsive symptoms/disorder with clozapine: A retrospective study from a multispeciality tertiary care centre. Grover S; Hazari N; Chakrabarti S; Avasthi A Asian J Psychiatr; 2015 Jun; 15():56-61. PubMed ID: 26013671 [TBL] [Abstract][Full Text] [Related]
49. Clozapine-Associated Obsessive-Compulsive Symptoms and Their Management: A Systematic Review and Analysis of 107 Reported Cases. Kim DD; Barr AM; Lu C; Stewart SE; White RF; Honer WG; Procyshyn RM Psychother Psychosom; 2020; 89(3):151-160. PubMed ID: 32045914 [TBL] [Abstract][Full Text] [Related]
50. Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline. Allen L; Tejera C Am J Psychiatry; 1994 Jul; 151(7):1096-7. PubMed ID: 8010373 [No Abstract] [Full Text] [Related]
51. Suicidality in clozapine-treated patients with schizophrenia: role of obsessive-compulsive symptoms. Szmulewicz AG; Smith JM; Valerio MP Psychiatry Res; 2015 Nov; 230(1):50-5. PubMed ID: 26260567 [TBL] [Abstract][Full Text] [Related]
52. Olanzapine and obsessive-compulsive symptoms. Lykouras L; Zervas IM; Gournellis R; Malliori M; Rabavilas A Eur Neuropsychopharmacol; 2000 Sep; 10(5):385-7. PubMed ID: 10974610 [TBL] [Abstract][Full Text] [Related]
53. Distinct risk factors for obsessive and compulsive symptoms in chronic schizophrenia. Fernandez-Egea E; Worbe Y; Bernardo M; Robbins TW Psychol Med; 2018 Dec; 48(16):2668-2675. PubMed ID: 29455687 [TBL] [Abstract][Full Text] [Related]
54. Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia. Kopala L; Honer WG Am J Psychiatry; 1994 Nov; 151(11):1714-5. PubMed ID: 7524373 [No Abstract] [Full Text] [Related]
55. Olanzapine-induced obsessive-compulsive disorder. Mottard JP; de la Sablonnière JF Am J Psychiatry; 1999 May; 156(5):799-800. PubMed ID: 10327925 [No Abstract] [Full Text] [Related]
56. Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients. Glick ID; Poyurovsky M; Ivanova O; Koran LM J Clin Psychiatry; 2008 Dec; 69(12):1856-9. PubMed ID: 19026264 [TBL] [Abstract][Full Text] [Related]
57. Clozapine, obsessive symptoms, and serotonergic mechanisms. Steingard S; Chengappa KN; Baker RW; Schooler NR Am J Psychiatry; 1993 Sep; 150(9):1435. PubMed ID: 8352369 [No Abstract] [Full Text] [Related]